Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-24-005418

EVP & Chief Medical Officer sold 3,321 shares at $10.24 ($34,006)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pang Phillip EVP & Chief Medical Officer 2024-02-16 Sale 10b5-1 −3,321 $10.24 $34,006 264,679 D
Open-market sales · 3,321 sh · avg $10.24 · $34,006
Loading xslF345X05/wk-form4_1708127793.xml…